Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1059–1065. doi: 10.1001/jamaoto.2015.2158

Table 1.

Demographic Characteristics, Clinicopathologic Information, and Univariate Association of Oncologic Risk Factors and 1-Year Mortality

No. (%) of Patientsa
Survival
Variable All (N = 191) ≥1 Year (n = 138) <1 Year (n = 53) P Value
Cancer subsite

    Larynx 72 (37.7) 56 (40.6) 16 (30.2) <.001b

    Oral cavity 72 (37.7) 50 (36.2) 22 (41.5)

    Oropharynx 38 (19.9) 27 (19.6) 11 (20.8)

    Hypopharyx 9 (4.7) 5 (3.6) 4(7.5)

Sex

    Female 55 (28.8) 40 (29.0) 15 (28.3) .93

    Male 136 (71.2) 98 (71.0) 38 (71.7)

Smoking history

    Never 27 (14.1) 15 (10.9) 12 (22.6) .04b

    Former or current 158 (82.7) 118 (85.5) 40 (75.5)

Alcohol history

    None 50 (26.2) 35 (25.4) 15 (28.3) .95

    Former or current alcohol history 122 (63.9) 86 (62.3) 36 (67.9)

T stagec

    1 72 (37.7) 63 (45.7) 9 (17.0) <.001b

    2 61 (31.9) 42 (30.4) 19 (35.8)

    3 35 (18.3) 19 (13.8) 16 (30.2)

    4 19 (9.9) 10 (7.2) 9 (17.0)

N stagec

    N0/1 135 (70.7) 103 (74.6) 32 (60.4) .02b

N2 or less 46 (24.1) 27 (19.6) 19 (35.8)

Closure

    Free flap 30 (15.7) 17 (12.3) 13 (24.5) .05b

    Primary closure or pedicledflap 97 (50.8) 73 (52.9) 24 (45.3)

Primary radiotherapy

    Yes 93 (48.7) 69 (50.0) 24 (45.3) .56

    No 98 (51.3) 69 (50.0) 29 (55.7)

Adjuvant therapy

    None 103 (53.9) 80 (58.0) 23 (43.4) .009b

    Radiation 31 (16.2) 20 (14.5) 11 (20.8)

    Radiation and chemotherapy 20 (10.5) 9 (6.5) 11 (20.8)

Disease-free interval,mo

    <6 91 (47.6) 56 (40.6) 35 (66.0) .002b

    ≥6 100 (52.4) 82 (59.4) 18 (34.0)

Primary extracapsular spread

    Yes 17 (8.9) 5 (3.6) 12 (22.6) .89

    No 8 (4.2) 2 (1.4) 6 (11.3)

HPV status

    Positive 9 (4.7) 7 (5.1) 2 (3.8) .43

    Negative 25 (13.1) 14 (10.1) 11 (20.8)

Primary perineural invasion

    Yes 26 (13.6) 14 (10.1) 12 (22.6) .20

    No 49 (25.7) 35 (25.4) 14 (26.4)

Primary mandible procedure

    Yes 20 (10.5) 12 (8.7) 8 (15.1) .29

    No 144 (75.4) 105 (76.1) 39 (73.6)

Primary positive margin

    Yes 9 (4.7) 6 (4.3) 3 (5.7) >.99

    No 74 (38.7) 47 (34.1) 27 (50.9)
a

Total No. (%) discrepancies are a result of data points answered as unknown or not applicable.

b

Statistically significant (P < .05).

c

Staging of primary disease at the time of initial diagnosis.